)
Poltreg (PTG) investor relations material
Poltreg Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue from product sales reached 350 thousand PLN in 2025, unchanged from 2024, due to delays in regulatory approval for the main customer.
Net loss increased to 25,999 thousand PLN in 2025 from 18,708 thousand PLN in 2024, reflecting higher operating expenses.
The company remains focused on advanced clinical-stage Treg cell therapies for autoimmune diseases, with significant R&D and grant activity.
Financial highlights
Operating loss widened to 26,204 thousand PLN in 2025 from 20,279 thousand PLN in 2024.
Total assets decreased to 72,958 thousand PLN at year-end 2025 from 102,379 thousand PLN in 2024.
Cash and equivalents dropped to 17,785 thousand PLN from 45,655 thousand PLN year-over-year.
Net cash outflow from operating activities was 27,873 thousand PLN, up from 16,005 thousand PLN in 2024.
Basic and diluted loss per share were (5.58) PLN and (5.32) PLN, respectively, compared to (4.01) PLN and (3.83) PLN in 2024.
Outlook and guidance
No indicators of going concern risk identified; recent capital increase supports short- and medium-term objectives.
Ongoing and new grant-funded projects, including those in preclinical and clinical phases, are expected to drive future development.
- Net loss nearly doubled as revenue fell, but key clinical and grant milestones were achieved.PTG
Q2 202411 Mar 2026 - Revenue dropped sharply as clinical and regulatory progress accelerated, with losses offset by strong cash and grants.PTG
Q4 202411 Mar 2026 - Losses increased as revenue fell, but clinical and patent milestones position the pipeline for future growth.PTG
Q3 202411 Mar 2026 - Net loss widened on higher R&D costs, but clinical and regulatory milestones advanced.PTG
Q3 202511 Mar 2026 - Q1 2025 marked higher losses, no sales, and key advances in TREG therapy R&D and partnerships.PTG
Q1 202511 Mar 2026 - Net loss deepened, cash reserves fell, but major clinical and regulatory milestones were achieved.PTG
Q2 202511 Mar 2026
Next Poltreg earnings date
Next Poltreg earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)